, -. , β1-, - β1- β2-. β-, , .. , :1) , , .. II, , ;
2) , () , , . , , β- . , ;
3) - β-, , - [6].
:
- 5 INSIGHT, NICS-EH, STOP-2, NORDIL VHAS ( 23 454 ) - . , , , - , - [14]. - STOP-2, UKPDS-HDS CAPPP ( 16 161 ) - . - . . , 80 , , 32% , , . , , , [19].
Cardiorenal Med. 2016 Aug;6(4):261-8. doi: 10.1159/000445302. Epub 2016 Apr 23.
, BOLD MR - 38 . - (β = 8,4, = 0,008). - , , , . .
|
|
-, 15 ( 35 . ), , (1 199 , ). , , . , , , , [20].
. 1%, 25% . , 46%.
TIBBS (Total Ischemic Burden Bisoprolol Study), , .
: , , , , / .
- . ., . ., . ., . . : , . // . 2008; 12: . 1013.
- Heart Disease and Stroke Statistics-2006 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee // Circulation. 2006; 113; e85e151.
- Dzau V. J., Antman E. M., Black H. R. et al. The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes Part I: Pathophysiology and Clinical Trial Evidence (Risk Factors Through Stable Coronary Artery Disease) // Circulation. 2006; 114; 28502870.
- Wehling M. Multimorbidity and polypharmacy: which betablocker to use in relation to the pharmacokinetic profile and interaction potential // Arzneimittelforschung. 2010; 60 (2): 5763.
- The Task Force on Beta-Blockers of the European Society of Cardiology. Expert consensus document on b-adrenergic receptor blockers // Eur Heart J. 2004; 25: 13411362.
- Cruickshank J. M., Prichard B. N. C. Beta-adrenoreceptors. In: Cruickshank J. M., Prichard B. N. C., editors. Beta-blockers in clinical practice. London: Churchill Livingstone; 1996, p. 986.
- ESH-ESC Guidelines Committee. 2007 guidelines for the management of arterial hypertension. J Hypertension 2007; 25: 11051187.
- . . . , 2009, . 534.
- Guidelines on the management of stable angina pectoris: executive summary. The task force of the management of stable angina pectoris of the European Society of Cardiology // Eur Heart J. 2006; 27: 133481.